Bioactive glass versus autologous platelet-rich fibrin for treating periodontal intrabony defects: A comparative clinical study
- PMID: 29386798
- PMCID: PMC5767987
- DOI: 10.4103/0972-124X.201628
Bioactive glass versus autologous platelet-rich fibrin for treating periodontal intrabony defects: A comparative clinical study
Abstract
Background: To compare treatment modalities: Open flap debridement (OFD) alone (Group I), OFD in combination with PerioGlas® (Group II), and OFD in combination with autologous platelet-rich fibrin (PRF) (Group III) for periodontal intrabony defects (IBDs).
Aim: To evaluate on clinical and radiographic basis, effectiveness of PerioGlas®, and PRF in treating IBDs.
Settings and design: IBDs selected on the basis of the inclusion criteria were randomly assigned to Groups I, II, and III by coin toss method.
Materials and methods: The study was conducted on patients reporting to the department of periodontology and oral implantology. Thirty-eight patients with ninety periodontal IBDs of moderate to severe periodontitis were selected and assigned to Groups I, II, and III. In each patient, a minimum number of two sextants were present with pocket depths ≥5 mm in at least three teeth.
Statistical analysis: Statistical analysis based on mean values, standard deviation, and P values.
Results: Compared to baseline, 9 months postoperatively: (1) mean probing pocket depth reduction for Group I was 3.68 mm ± 0.72, for Group II was 5.57 mm ± 1.10, and for Group III was 6.11 mm ± 0.92. (2) The mean relative attachment level gain for Group I was 4.14 mm ± 0.76, for Group II was 6.57 mm ± 1.45, and for Group III was 6.74 mm ± 1.55. (3) Mean radiographic IBD fill for Group I was 69.29% mm ± 7.73, for Group II was 74.44% mm ± 8.57, and for Group III was 75.01% mm ± 7.85.
Conclusion: This study shows marked improvements in the clinical parameters and radiographic outcomes with both PerioGlas® and autologous PRF to treat periodontal IBDs as compared to OFD alone.
Keywords: Autologous platelet-rich fibrin; bioactive glass (PerioGlas®); intrabony defects; open flap debridement.
Conflict of interest statement
There are no conflicts of interest.
Figures


References
-
- Papapanou PN, Tonetti MS. Diagnosis and epidemiology of periodontal osseous lesions. Periodontol 2000. 2000;22:8–21. - PubMed
-
- Schallon RA. Diagnosis and management of vertical bone defects in periodontal disease. Gen Dent. 2012;60:290–7. - PubMed
-
- Wang HL, Greenwell H. Surgical periodontal therapy. Periodontol 2000. 2001;25:89–99. - PubMed
-
- Villar CC, Cochran DL. Regeneration of periodontal tissues: Guided tissue regeneration. Dent Clin North Am. 2010;54:73–92. - PubMed
-
- Graziani F, Gennai S, Cei S, Cairo F, Baggiani A, Miccoli M, et al. Clinical performance of access flap surgery in the treatment of the intrabony defect. A systematic review and meta-analysis of randomized clinical trials. J Clin Periodontol. 2012;39:145–56. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources